To provide technical support to the country in the process of COVID vaccine registration and vaccine deployment.

On January 30th, 2020 the World Health Organization declared 2019-nCoV disease as a Public Health Emergency of International Concern (PHEIC) and on February 11th, 2020 the WHO named the disease caused by the virus SARS-CoV-2 as COVID-19, which references the type of virus and the year. On March 13th (week 11/2020) Sudan FMoH declared the first COVID-19 case. Up to Monday February 1st, 2021 a total of 49,446 suspected cases reported in Sudan of which 27,402 (55.4%) tested positive including 1829 associated deaths, CFR: 6.6%. Active cases signify 14.4% of the total confirmed cases.

GAVI open a widow to support, with overall objective of Protect public health and minimize societal and economic impact by reducing COVID-19 mortality, the COVAX Facility is administered by the Gavi Secretariat and implemented in partnership with WHO and ACT Accelerator actors. Countries are divided in to two groups based on income level, Low-income (LIC) and Low middle income (LMIC) countries GNI <US$4,046 Supported by Gavi Advanced Market Commitment (AMC), Sudan is one of the countries eligible for the AMC support. The objective of this consultancy is technically supporting the country in the process of vaccine registration and preparation of Emergency Use Authorization (EUA) based on WHO Emergency Use Listing (EUL).

Output 1: The consultant in consultation with the MOH team will support the process of the COVAX vaccine introduction in Sudan.
Deliverables 1.1: Prepare the required documents and the EUA needed for regulatory approvals of COVID-19 vaccines clarified by the national regulator/authority as per the information of the shipments and the manufacturers from COVAX
Deliverables 1.2 : Follow on release of the indemnity for the COVID vaccines as per COVX facility
Consultants_TermsOfReferenceTemplate_Version2_20160329

Deliverables 1.3 Support and follow preparation of import permits for medical products, based on a minimum number of documentation requirements, as quickly as possible. Vaccines procured from assured sources do not need to be tested again and to ensure release these vaccines to the immunization programme in the shortest possible time.
Deliverables 1.4 : Provide Technical reports of:
• All vaccines got the Emergency Use Authorization (EUA) from NRA
• For the preparation process of receiving vaccine shipments
• Vaccine arrival reports

Qualifications required: Essential: First university degree in Medicine, Public Health, Health Services Planning or equivalent relevant discipline.
Desirable: Additional training in EPI programme management, planning and vaccine introduction process.
- Experience required: 5 years of experience in EPI programme management, planning and vaccine introduction process
- Skills / Technical skills and knowledge:
• Aware of country context and profile
• Awareness of all NRA requirement, the country policy and regulation
• Awareness with COVAX facility, COVID vaccines efficiency, approval, and availability through COVAX facility
• Good capacity in following the updated WHO data on COVID vaccines approval
- Language requirements:
Languages and level required (Read - Write - Speak / Expert or Intermediate)

How to apply:

Interested applicants are requested to send their updated C.Vs to: emacosudhr@who.int with vancy name on the subject  not later than Saturday 12th June, 2021 at 3:00PM Sudan Time.

Only candidates under serious consideration will be contacted for interview.